Neurology
-
Randomized Controlled Trial Multicenter Study
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
To assess the utility of orexin receptor antagonism as a novel approach to treating insomnia. ⋯ This study provides Class I evidence that suvorexant improves sleep efficiency over 4 weeks in nonelderly adult patients with primary insomnia.